我国慢性肾病患者中高血压患病率的变化
摘要
目的基于2017ACC/AHA高血压指南和2010中国高血压指南,探讨我国慢性肾病(CKD)患者中高血压患病率的变化。方法以中国健康与营养调查(CHNS)2009年数据库为研究对象,分析CKD(n=1413)成年患者中高血压患病率的变化,并进行亚组分析。结果根据2010中国高血压防治指南,我国CKD患者中高血压患病率为47.2%;而根据2017美国ACC/AHA指南,患病率则高达74.7%。亚组分析显示,男性患病率差异低于女性(P<0.001),65岁以上人群患病率差异低于其他年龄段人群(P<0.001),而在城市和农村之间无差异(P=0.736)。未服降压药人群中,血压在130～139/80～89mmHg的人群所占比例最高(27.5%)。结论因为诊断标准的不同,采用2017美国高血压ACC/AHA指南的定义,将会使我国CKD患者中高血压患病率显著上升。
引文
[1]C Yang,J Wang,B Gao,et al.Prevalence and treatment of hypertension in China:impacts of 2017 American College of Cardiology/A-merican Heart Association High Blood Pressure Guideline.Science Bulletin,2018,63(8):488-493.
[2]Lu J,Lu Y,Wang X,et al.Prevalence,awareness,treatment,and control of hypertension in China:data from 1·7 million adults in a population-based screening study(China PEACE M illion Persons Project).Lancet,2017,390(10112):2549-2558.
[3]Whelton PK,Carey RM,Aronow WS,et al.2017 ACC/AHA/AA-PA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM A/PCNA Guideline for the Prevention,Detection,Evaluation and M anagement of High Blood Pressure in Adults.J Am Coll Cardiol,2018,71:e127-e248.
[4]Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure:the JNC 7 report.JAM A,2003,289(19):2560-2571.
[5]张路霞,王海燕.中国慢性肾脏病的现状及挑战:来自中国慢性肾脏病流行病学调查的启示.中华内科杂志,2012,51(7):497-498.
[6]阮志芹,李华.原发性高血压和肾功能减退的相关性.中华高血压杂志,2017,25(1):22-26.
[7]Batis C,Mendez MA,Gordonlarsen P,et al.Using both Principal Component Analysis and Reduced Rank Regression to Study Dietary Patterns and Diabetes in Chinese Adults.Public Health Nutr,2016,19(2):195-203.
[8]CHNS China Health and Nutrion Survey[cited 2018 April 17,2018].Available from:http://w w w.cpc.unc.edu/projects/china/about/proj_desc/survey.
[9]CHNS China Health and Nutrition Survey[cited 2018 April 17,2018].Available from:http://w w w.cpc.unc.edu/projects/china/data/datasets/biomarker-data.
[10]Yan S,Li J,Li S,et al.The expanding burden of cardiometabolic risk in China:the China Health and Nutrition Survey.Obes rev,2012,13(9):810-821.
[11]Whelton PK,Carey RM,Aronow WS,et al.2017 ACC/AHA/AA-PA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM A/PCNA Guideline for the Prevention,Detection,Evaluation,and M anagement of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Hypertension,2018,71(6):e13-e115.
[12]刘力生.中国高血压防治指南2010.中华高血压杂志,2011,19(8):701-743.
[13]O'Callaghan C A,Shine B,Lasserson D S.Chronic kidney disease:a large-scale population-based study of the effects of introducing the CKD-EPI formula for e GFR reporting.BM J Open.2011;1:e000308.
[14]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要.中国循环杂志,2018,33(1):1-8.
[15]Muntner P,Carey RM,Gidding S,et al.Potential U.S.Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline.Circulation,2018,137(2):109-118.
[16]黄绮芳,王继光.亚洲慢性肾脏病患者的血压管理.中华高血压杂志,2017,25(3):219-223.
[2]Lu J,Lu Y,Wang X,et al.Prevalence,awareness,treatment,and control of hypertension in China:data from 1·7 million adults in a population-based screening study(China PEACE M illion Persons Project).Lancet,2017,390(10112):2549-2558.
[3]Whelton PK,Carey RM,Aronow WS,et al.2017 ACC/AHA/AA-PA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM A/PCNA Guideline for the Prevention,Detection,Evaluation and M anagement of High Blood Pressure in Adults.J Am Coll Cardiol,2018,71:e127-e248.
[4]Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure:the JNC 7 report.JAM A,2003,289(19):2560-2571.
[5]张路霞,王海燕.中国慢性肾脏病的现状及挑战:来自中国慢性肾脏病流行病学调查的启示.中华内科杂志,2012,51(7):497-498.
[6]阮志芹,李华.原发性高血压和肾功能减退的相关性.中华高血压杂志,2017,25(1):22-26.
[7]Batis C,Mendez MA,Gordonlarsen P,et al.Using both Principal Component Analysis and Reduced Rank Regression to Study Dietary Patterns and Diabetes in Chinese Adults.Public Health Nutr,2016,19(2):195-203.
[8]CHNS China Health and Nutrion Survey[cited 2018 April 17,2018].Available from:http://w w w.cpc.unc.edu/projects/china/about/proj_desc/survey.
[9]CHNS China Health and Nutrition Survey[cited 2018 April 17,2018].Available from:http://w w w.cpc.unc.edu/projects/china/data/datasets/biomarker-data.
[10]Yan S,Li J,Li S,et al.The expanding burden of cardiometabolic risk in China:the China Health and Nutrition Survey.Obes rev,2012,13(9):810-821.
[11]Whelton PK,Carey RM,Aronow WS,et al.2017 ACC/AHA/AA-PA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM A/PCNA Guideline for the Prevention,Detection,Evaluation,and M anagement of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Hypertension,2018,71(6):e13-e115.
[12]刘力生.中国高血压防治指南2010.中华高血压杂志,2011,19(8):701-743.
[13]O'Callaghan C A,Shine B,Lasserson D S.Chronic kidney disease:a large-scale population-based study of the effects of introducing the CKD-EPI formula for e GFR reporting.BM J Open.2011;1:e000308.
[14]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要.中国循环杂志,2018,33(1):1-8.
[15]Muntner P,Carey RM,Gidding S,et al.Potential U.S.Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline.Circulation,2018,137(2):109-118.
[16]黄绮芳,王继光.亚洲慢性肾脏病患者的血压管理.中华高血压杂志,2017,25(3):219-223.